Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Novel inflammatory markers, clinical risk factors and virus type associated with severe respiratory syncytial virus infection.

Tabarani CM, Bonville CA, Suryadevara M, Branigan P, Wang D, Huang D, Rosenberg HF, Domachowske JB.

Pediatr Infect Dis J. 2013 Dec;32(12):e437-42. doi: 10.1097/INF.0b013e3182a14407.

2.

Immunopathogenesis of respiratory syncytial virus bronchiolitis.

Bennett BL, Garofalo RP, Cron SG, Hosakote YM, Atmar RL, Macias CG, Piedra PA.

J Infect Dis. 2007 May 15;195(10):1532-40. Epub 2007 Apr 12.

3.

Severity of respiratory syncytial virus disease related to type and genotype of virus and to cytokine values in nasopharyngeal secretions.

Hornsleth A, Klug B, Nir M, Johansen J, Hansen KS, Christensen LS, Larsen LB.

Pediatr Infect Dis J. 1998 Dec;17(12):1114-21.

PMID:
9877358
4.

CD4+ T-cell counts and interleukin-8 and CCL-5 plasma concentrations discriminate disease severity in children with RSV infection.

Brand HK, Ferwerda G, Preijers F, de Groot R, Neeleman C, Staal FJ, Warris A, Hermans PW.

Pediatr Res. 2013 Feb;73(2):187-93. doi: 10.1038/pr.2012.163. Epub 2012 Nov 19.

PMID:
23165450
5.

Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease.

Sheeran P, Jafri H, Carubelli C, Saavedra J, Johnson C, Krisher K, Sánchez PJ, Ramilo O.

Pediatr Infect Dis J. 1999 Feb;18(2):115-22.

PMID:
10048682
6.

Comparison of risk factors for human metapneumovirus and respiratory syncytial virus disease severity in young children.

Papenburg J, Hamelin MÈ, Ouhoummane N, Carbonneau J, Ouakki M, Raymond F, Robitaille L, Corbeil J, Caouette G, Frenette L, De Serres G, Boivin G.

J Infect Dis. 2012 Jul 15;206(2):178-89. doi: 10.1093/infdis/jis333. Epub 2012 May 2.

7.

Innate immune dysfunction is associated with enhanced disease severity in infants with severe respiratory syncytial virus bronchiolitis.

Mella C, Suarez-Arrabal MC, Lopez S, Stephens J, Fernandez S, Hall MW, Ramilo O, Mejias A.

J Infect Dis. 2013 Feb 15;207(4):564-73. doi: 10.1093/infdis/jis721. Epub 2012 Nov 29.

8.
9.

T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol.

Pinto RA, Arredondo SM, Bono MR, Gaggero AA, Díaz PV.

Pediatrics. 2006 May;117(5):e878-86. Epub 2006 Apr 17.

PMID:
16618789
10.

Peripheral blood cytokine responses and disease severity in respiratory syncytial virus bronchiolitis.

Bont L, Heijnen CJ, Kavelaars A, van Aalderen WM, Brus F, Draaisma JT, Geelen SM, van Vught HJ, Kimpen JL.

Eur Respir J. 1999 Jul;14(1):144-9.

12.

Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group.

Rodriguez WJ, Gruber WC, Welliver RC, Groothuis JR, Simoes EA, Meissner HC, Hemming VG, Hall CB, Lepow ML, Rosas AJ, Robertsen C, Kramer AA.

Pediatrics. 1997 Mar;99(3):454-61.

PMID:
9041304
13.

IL-10 and RANTES are elevated in nasopharyngeal secretions of children with respiratory syncytial virus infection.

Murai H, Terada A, Mizuno M, Asai M, Hirabayashi Y, Shimizu S, Morishita T, Kakita H, Hussein MH, Ito T, Kato I, Asai K, Togari H.

Allergol Int. 2007 Jun;56(2):157-63. Epub 2007 May 1.

15.

Respiratory syncytial virus and influenza virus infections: observations from tissues of fatal infant cases.

Welliver TP, Reed JL, Welliver RC Sr.

Pediatr Infect Dis J. 2008 Oct;27(10 Suppl):S92-6. doi: 10.1097/INF.0b013e318168b706.

PMID:
18820587
16.

[Severity of respiratory syncytial virus infection influenced by clinical risk factors and subtype A and B in hospitalized children].

Bergsträsser E, Zbinden R, Minder C, Gnehm HE.

Klin Padiatr. 1998 Nov-Dec;210(6):418-21. German.

PMID:
9871899
17.

Motavizumab treatment of infants hospitalized with respiratory syncytial virus infection does not decrease viral load or severity of illness.

Ramilo O, Lagos R, Sáez-Llorens X, Suzich J, Wang CK, Jensen KM, Harris BS, Losonsky GA, Griffin MP; Motavizumab Study Group.

Pediatr Infect Dis J. 2014 Jul;33(7):703-9. doi: 10.1097/INF.0000000000000240.

PMID:
24356256
19.
20.

Effect of dexamethasone on respiratory syncytial virus-induced lung inflammation in children: results of a randomized, placebo controlled clinical trial.

Somers CC, Ahmad N, Mejias A, Buckingham SC, Carubelli C, Katz K, Leos N, Gomez AM, DeVincenzo JP, Ramilo O, Jafri HS.

Pediatr Allergy Immunol. 2009 Aug;20(5):477-85. doi: 10.1111/j.1399-3038.2009.00852.x. Epub 2009 Apr 24.

PMID:
19397752
Items per page

Supplemental Content

Write to the Help Desk